Table 1.
Reference/intervention | Study type | Number of | Follow-up | Outcomes | |||||
---|---|---|---|---|---|---|---|---|---|
Patients | Hips | Graf D/II/IV) | Duration | Loss to follow-up | Primary | Secondary | Complications | ||
PICO 1: Pavlik harness vs other abduction devices | |||||||||
Zidka et al. (14) | RCCS | ||||||||
Pavlik harness | 137 | 48 | 119 days | 16 patients (14%) | Graf I ultrasound: 100% | ||||
Frejka pillow | 145 | 26 | 95 days | 7 patients (5%) | Graf I ultrasound: 100% | ||||
Wilkinson et al. (15) | RCCS | 6–12 months | 0% | None | |||||
(i) Craig splint | 28 | Spica cast: 3 hips (10.7%); Operation: 1 hip (3.6%) |
|||||||
(ii) Pavlik harness | 43 | Spica cast: 10 hips (23.3%); Operation: 3 hips (7%) |
|||||||
(iii) Von Rosen splint | 26 | Spica cast: 0; Operation: 0 |
|||||||
No splint | 37 | Spica cast: 8 hips (21.6%); Operation: 2 hips (5.4%) |
|||||||
Atar et al. (16) | RCCS | ||||||||
Pavlik harness | 40 | 48 | 1.8 years (1–5) | 0% | Successful reduction: 42/48 (88%) | AVN 3/48 (6%) | |||
Frejka splint | 70 | 84 | 1.5 (1–4) 0% | 0% | Successful reduction: 76/84 (90%) | AVN 6/84 (7%) | |||
PICO 2: Closed reduction restricted by limited hip abduction – traction vs adductor tenotomy | |||||||||
Carney et al. (17) | RCRS | ||||||||
Traction | 2 | 91 months (24–163) | N/A | Successful reduction: 100% | Residual dysplasia 2/2 (100%) |
AVN 1/2 (50%) | |||
Adductor longus tenotomy | 8 | Successful reduction: 100% | Residual dysplasia 6/8 (75%) |
AVN 2/8 (25%) | |||||
Closed reduction without traction or tenotomy | 5 | Successful reduction: 100% | Residual dysplasia 5/5 (100%) |
AVN 3/9 (33%) | |||||
Both traction and tenotomy | 5 | Successful reduction: 100% | Residual dysplasia 2/5 (40%) |
AVN 2/5 (40%) | |||||
PICO 3: Unsuccessful closed reduction – surgical reduction through a medial or anterior approach vs other surgical approaches | |||||||||
Duman et al. (18) | RCCS | AVN and femoral neuropathy | |||||||
Arthroscopic-assisted | 26 | 26 | 24 months (24–30) | 4 | Successful reduction: 26/26; Successful functional outcome (MacKay score): 18 (81.8%); AI: 27° (19–36); | Blood loss: 9 mL (5–15); Operative time: 32 min (30–40) | 0 | ||
Medial approach (Ludloff) | 28 | 28 | Successful reduction: 27/28; Successful functional outcome (MacKay score): 17 (80.9%); AI: 26° (11–39); | Blood loss: 35 mL (15–55); Operative time: 34 min (30–40) | 0 | ||||
Yorgancigil et al. (19) | RCCS | Successful functional outcome (MacKay)(P = 0.23); AI postoperative P = 0.226 |
Revision surgery (P = 0.170) | AVN and femoral neuropathy (P= 0.933) | |||||
Anterior approach | 17 | 22 | 84.0 ± 29.5 months | NR | 18 hips (81.8%); AI postoperative: 21.23° ± 3.70 | 4 hips (18.1%) | 5 hips (22.7%) | ||
Medial approach | 19 | 21 | 75.2 ± 19.6 months | NR | 17 hips (80.9%); AI postoperative: 21.86° ± 3.93 | 3 hips (14.3%) | 5 hips (23.8%) | ||
Hoellwarth et al. (20) | RCCS | AI, mean (P = 0.23) | Revision surgery (P = 0.48) | AVN and femoral neuropathy), P= 0.32 |
|||||
Anterior approach | 18 | 19 | 6.2 ± 3.2 months | NR; Incomplete data: 22 | 17° (6–25) | 7 hips (37%) | 10 hips (53%) | ||
Medially based approach | 14 | 19 | 6.1 ± 2.8 months | NR; Incomplete data: 2 | 19° (11–33) | 4 hips (21%) | 6 hips (32%) | ||
Holman et al. (21) | RCCS | Successful reduction | AVN, femoral neuropathy and osteonecrosis | ||||||
Anterior approach | 141 for surgery; 48 in follow-up study | 27 years (13–54) | 96 hips | 9 (19%) re-dislocations | 20 hips (42%) | 9 hips (18.8%) | |||
Medial approach Ludloff | 38 for surgery; 18 in follow-up study | 20 hips | 2 (11%) re-dislocations | 9 hips (50 %) | 1 hip (6 %) | ||||
Tarasolli et al. (22) | PCS | Successful reduction | Acetabular index (P= 0.18) | AVN, femoral neuropathy, and osteonecrosis (P = 0.52) | |||||
Anterior approach | 21 | 22 | 61 months (28–100) | 1 | 0 re-dislocations | Absolute mean: 24° (15°–34°)Mean decrease: 7.9° (6°–10°) | 4 (18%) | ||
Medial approach | 22 | 26 | 77 months (26–228) | 0 | 1 (4%) re-dislocations | Absolute mean: 25° (16°–35°)Mean decrease: 8.8° (4°–12°) | 3 (12%) | ||
Matsushita et al. (23) | RCCS | 11–14 months | NR | Successful functional outcome (MacKay), | Due to (sub)luxation | AVN, femoral neuropathy, and osteonecrosis | |||
Wide exposure method | 27 | 32 | 24 (77.4%); Residual dysplasia: 4 hips (12.9%) class III, 1 hip (3.2%) class IV |
0 | 1 hip (3.2%) | ||||
Medial approach | 24 | 31 | 24 (75%); Residual dysplasia: 11 hips (34.4%) class III, 3 hips (9.4%) class IV; P<0.05 |
10 hips (31.3%) | 7 hips (21.9%) | ||||
PICO 4: After successful surgical reduction (closed or open) – short period of spica cast treatment compared vs longer period | |||||||||
Emara et al. (26) | RCCS | ±12 years | NR | Clinical assessments according to McKay criteria (P = 0.612) | Radiographic assessment according to Severin classification (P = 0.449) | ||||
Spica removed after 4 weeks followed by abduction brace | 32 | 38 | E = 81.6%, G= 18.4% | Ia= 81.6%, Ib =15.8% | AVN: 15.8%; (P = 0.015); Other: 0 hips | ||||
Spica removed after 12 weeks, then started ambulation without brace | 24 | 29 | E = 86.2%, G= 13.8% | Ia = 69%, Ib = 24.1%, II = 6.9% | AVN: 48.3%; Other: 5 hips; (P = 0.029) |
AI, acetabular index; PCS, prospective cohort study; RCCS, retrospective comparative cohort study; RCRS, retrospective chart review study.